Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › Billing code Q5114

Q5114

Injection, trastuzumab-dkst, biosimilar, (ogivri), 10 mg

Medicaid paid $5.10M on code Q5114 from 2018 through 2024, to 12 providers — the #2,536 code in the file by dollars. 50% of it was billed in California.

28Total paid$5.10M
24GClaims3,072
Paid per claim line$2K
33Providers billing it12
Box 32 · Location

Where Q5114 is billed

  1. $2.5M
  2. $1.4M
  3. $463K
  4. $441K
  5. $240K
  6. $67K

The largest of 6 states and territories, by the billing provider's address. States cover different services and set their own rates, so the same code can mean different things in different programs.

Ranked

Top providers billing Q5114

#ProviderLocationClaimsPaid on Q5114
1 Boston Medical Center Corporation Boston, MA 1,046 $1.36M
2 Desert Regional Medical Center, INC. Palm Springs, CA 85 $1.27M
3 ST. Joseph Hospital of Orange Orange, CA 818 $621K
4 Swedish Health Services Seattle, WA 317 $463K
5 Maimonides Medical Center Brooklyn, NY 242 $441K
6 Los Angeles Hematology-Oncology Medical Group Los Angeles, CA 147 $239K
7 The Hospital of Central Connecticut at New Britain General and Bradley New Britain, CT 166 $211K
8 Ramesh Moolani, MD INC Chula Vista, CA 77 $196K
9 Regents of the University of California San Diego, CA 88 $165K
10 Dayton Osteopathic Hospital Dayton, OH 40 $67K
11 Pomona Valley Hospital Medical Center Pomona, CA 23 $39K
12 Hartford Hospital Hartford, CT 23 $29K